Ferrous Sulfate: Nursing Drug Guide, Iron Overdose & NCLEX Review

Ferrous sulfate is available generically and as store-brand iron supplements. Common U.S. trade names include Feosol and various OTC iron tablets and elixirs. Products may be labeled as ferrous sulfate, dried ferrous sulfate, or “iron supplement,” and strengths are often expressed as 325 mg ferrous sulfate (about 65 mg elemental iron) per tablet.

Always verify salt form, elemental iron per dose, and whether the product is enteric-coated or immediate-release—administration instructions differ. Combination prenatal vitamins may already contain iron; reconcile totals before giving an additional tablet.

Oral ferrous sulfate is used to treat or prevent iron deficiency and iron deficiency anemia. U.S. OTC labeling states that treatment of any anemic condition should be under the advice and supervision of a doctor. In practice, nurses give prescribed iron when laboratory and clinical findings support deficiency—while monitoring response on repeat complete blood count and hemoglobin trends.

↔On a small screen, swipe or scroll sideways to see the full table.

Ferrous sulfate provides ferrous (Fe²⁺) iron, which is absorbed in the duodenum and proximal jejunum and used for hemoglobin synthesis, myoglobin, and enzymatic functions. Absorption is influenced by gastric acidity, concurrent foods and drugs, and the body’s iron status (absorption increases when stores are low). Nurses should pair teaching with realistic timelines: correcting anemia and relieving fatigue usually takes weeks, not one or two doses.

Dosing below reflects common U.S. OTC ferrous sulfate tablet labeling (DailyMed) and typical prescription practice. Prescriber orders and the specific product label prevail. Institutional protocols may vary.

Missed dose: Give when remembered unless near the next dose; do not double. If several doses are missed, notify the prescriber—do not catch up with extra tablets without orders (overdose risk, especially in children).

Pretreatment checks

• Confirm indication (deficiency vs routine supplement) and recent ferritin / hemoglobin / CBC per prescriber
• Screen for iron overload, hemochromatosis history, or repeated transfusions—iron may be contraindicated until clarified
• Review MAR for duplicate iron (prenatal vitamin + standalone tablet)
• Check interacting meds: oral tetracycline antibiotics (e.g. doxycycline), levothyroxine, omeprazole and other PPIs, calcium supplements, antacids
• Assess GI tolerance, swallowing ability, and whether enteric-coated tablets must be swallowed whole
• Complete medication reconciliation—home iron is a common source of pediatric exposure

Contraindications / do not use

• Known hypersensitivity to iron or formulation components—Not specified beyond standard allergy assessment in reviewed labeling
• Iron overload states (e.g. hemochromatosis, repeated transfusions with elevated ferritin)—hold and clarify; not appropriate for routine supplementation
• Acute iron poisoning—do not give oral iron; activate poison control / toxicology pathway

Important interactions

↔On a small screen, swipe or scroll sideways to see the full table.

Route: Oral tablet, elixir, or drops—follow medication administration rights and the product label.

• Timing: Many labels recommend taking after meals to reduce GI upset; some enteric products advise not chewing or crushing—verify formulation
• Swallow tablets with water; do not chew enteric-coated products unless label directs
• Use oral syringe for liquid iron; label and store securely out of children’s reach
• Document elemental iron dose (mg) when possible—not only “1 tab”

• Rising reticulocyte count within about 1 week when deficiency is treated—per standard hematology references; exact timing varies by severity
• Hemoglobin increase of roughly 1–2 g/dL over 2–4 weeks with adequate replacement and no ongoing blood loss—prescriber interprets labs
• Gradual improvement in fatigue, exercise tolerance, and pallor over weeks—not after a single dose
• Ferritin rise over months of therapy—used to document repletion

Stop oral iron and escalate immediately when toxicity, allergy, or failure to respond suggests another diagnosis:

• Suspected accidental ingestion (especially children)—poison control / toxicology per facility protocol; do not induce vomiting unless directed
• Severe vomiting, diarrhea, abdominal pain, hematemesis, shock, or altered mental status after iron ingestion
• Anaphylaxis or severe rash after dose
• No hematologic response despite compliant therapy—evaluate ongoing blood loss, malabsorption, or alternate anemia (B12 deficiency, chronic disease)
• True melena or hematochezia—do not attribute to iron alone; investigate bleeding

↔On a small screen, swipe or scroll sideways to see the full table.

U.S. OTC labeling carries a boxed warning: accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep out of reach of children. In case of accidental overdose, contact a doctor or poison control center immediately.

Antidote: Not specified in the reviewed OTC prescribing information. Management is directed by poison control or medical toxicology per facility protocol and local emergency guidance.

Signs nurses may recognize (supportive care focus)

• Acute ingestion: nausea, vomiting, abdominal pain, diarrhea (may be bloody), lethargy, shock
• Chronic excessive intake: iron overload—elevated ferritin, organ dysfunction—per prescriber evaluation

• Ferrous sulfate vs ferrous gluconate vs ferrous fumarate—different elemental iron per tablet; never substitute without pharmacy verification
• “325 mg” vs “65 mg elemental”—document which unit the order uses; double-check MAR against bottle
• Prenatal vitamin + separate iron—duplicate therapy and overdose risk
• Enteric-coated vs immediate-release—crushing enteric tablets may irritate stomach or alter absorption
• Liquid iron vs pediatric multivitamin with iron—measure with oral syringe; store separately from cough syrups

↔On a small screen, swipe or scroll sideways to see the full table.

↔On a small screen, swipe or scroll sideways to see the full table.

Monitor

• Hemoglobin / hematocrit and reticulocyte count per prescriber schedule (often ~2–4 weeks after starting therapy)
• Ferritin and iron studies when ordered—trend toward repletion over months
• GI tolerance: constipation, nausea, adherence
• Signs of ongoing blood loss (guaiac-positive stool, heavy menses, GI symptoms)

Document

• Product, elemental iron mg, time given, and spacing from interacting drugs
• Patient education on stool color, storage safety, and when to call
• Hold reasons and prescriber/pharmacy notification

• Take exactly as prescribed—do not exceed the recommended dose; extra tablets do not speed recovery and increase harm risk
• Keep iron locked away from children; child-resistant caps are not child-proof
• Stools may turn dark green or black—report severe belly pain, vomiting, bloody stools, or dizziness
• Separate iron from certain antibiotics and thyroid medicine per pharmacy instructions (often 2–4 hours)
• Expect gradual energy improvement over weeks; keep follow-up lab appointments

Do not give and contact the prescriber/pharmacist when:

Hold parameters may vary by institutional protocol. Follow prescriber orders, pharmacy guidance, and facility policy.

Rehearse NCLEX-style clinical judgment practice for ferrous sulfate using a tabbed outpatient case (MAR, labs, history, nursing notes), then priority action, cue recognition, hemoglobin trend interpretation, matrix urgency sorting, tetracycline spacing, and elemental-iron cloze—recognize cues → analyse → prioritise → act → evaluate outcomes.

This medication guide is written and reviewed using NurseOnShift editorial and clinical review standards.

• Editorial Policy
• Medical Review Process
• Disclaimer

Educational use only. This content does not replace clinical judgment, prescriber orders, pharmacist guidance, product labeling, or institutional protocols.